Lorenzo Antonuzzo (L Antonuzzo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Prognostic Factors

Immune Response

Metastatic Colorectal Cancer

Top Venues

Cancer research

Journal of biophotonics

Future oncology (London, England)

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy. Cancer research (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Dafne Suraci, Enrico Baria, Luca Tirloni, João L Lagarto, S Buccianti, C Agostini, Serena Pillozzi, Lorenzo Antonuzzo, Antonio Taddei, Riccardo Cicchi
Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe. Journal of biophotonics (2024)
Martina Catalano, Daniele Lavacchi, Elisa Giommoni, Sonia Shabani, Alessia Guidolin, Marco Brugia, Roberto Petrioli, Monica Ramello, Serena Pillozzi, Lorenzo Antonuzzo, Giandomenico Roviello
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI. Future oncology (London, England) (2023)
Daniele Rossini, Carlotta Antoniotti, Sara Lonardi, Filippo Pietrantonio, Roberto Moretto, Lorenzo Antonuzzo, Alessandra Boccaccino, Federica Morano, Marco Brugia, Carmelo Pozzo, Federica Marmorino, Francesca Bergamo, Emiliano Tamburini, Alessandro Passardi, Giovanni Randon, Sabina Murgioni, Beatrice Borelli, Angela Buonadonna, Mirella Giordano, Gabriella Fontanini, Veronica Conca, Vincenzo Formica, Massimo Aglietta, Roberto Bordonaro, Giuseppe Aprile, Gianluca Masi, Luca Boni, Chiara Cremolini
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, Michelino De Laurentiis, Marina Chiara Garassino, Carmine Pinto, Giovanni Rosti
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (12) (2022)
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study. Cancer medicine 11 (16) (2022)
Roberta Giorgione, Matteo Risaliti, Ilenia Bartolini, Gemma Rossi, Serena Pillozzi, Paolo Muiesan, Antonio Taddei, Lorenzo Antonuzzo
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers. Immunotherapy 14 (7) (2022)
Francesca Salvianti, Stefania Gelmini, Irene Mancini, Mario Pazzagli, Serena Pillozzi, Elisa Giommoni, Marco Brugia, Francesco Di Costanzo, Francesca Galardi, Francesca De Luca, Francesca Castiglione, Luca Messerini, Pamela Pinzani, Lorenzo Antonuzzo
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study. British journal of cancer 125 (1) (2021)